HLA class I and beta 2-microglobulin expression in frozen and formaldehyde-fixed paraffin sections of neuroblastoma tumors
- PMID: 3902214
HLA class I and beta 2-microglobulin expression in frozen and formaldehyde-fixed paraffin sections of neuroblastoma tumors
Abstract
Ten solid neuroblastoma tumors were examined for beta 2-microglobulin (beta 2-m) and HLA-class I expression in an immunocytochemical assay. Blood vessel endothelium and a small population of cells (less than 6% of small round cells) were consistently stained in frozen sections of each tumor. No beta 2-m or HLA-class I reactivity was detected in the remainder (greater than 94%) of the small round cells in each tumor. The localization of most of the positive cells near stromal tissue and blood vessels suggests that most of these cells may be of non-tumor origin. The patients from which the tumors were taken varied in degree of disease involvement, yet no differences with respect to beta 2-m and HLA-class I expression were found among the tumors. A procedure for visualizing beta 2-m and HLA-class I molecules in formaldehyde-fixed, paraffin-embedded tissue is described. This confirmed the results in frozen sections. These findings extend previous reports of weak beta 2-m and HLA-class I levels in cells of neuronal origin. The clinical implications are discussed.
Similar articles
-
Expression of mouse beta 2-microglobulin in frozen and formaldehyde-fixed central nervous tissues: comparison of tissue behind the blood-brain barrier and tissue in a barrier-free region.J Immunol. 1986 Oct 15;137(8):2561-6. J Immunol. 1986. PMID: 3531337
-
Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.Lab Invest. 1995 Jan;72(1):42-54. Lab Invest. 1995. PMID: 7837790
-
MHC regulation in neural cells. Distribution of peripheral and internal beta 2-microglobulin and class I molecules in human neuroblastoma cell lines.J Immunol. 1990 Jan 15;144(2):512-20. J Immunol. 1990. PMID: 2104897
-
Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications.Oncogene. 2005 Jul 7;24(29):4634-44. doi: 10.1038/sj.onc.1208594. Oncogene. 2005. PMID: 15897905
-
Monoclonal antibody analysis of MHC expression in human brain biopsies: tissue ranging from "histologically normal" to that showing different levels of glial tumor involvement.J Immunol. 1986 Jun 1;136(11):4054-62. J Immunol. 1986. PMID: 2422272
Cited by
-
Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma.Cancer Immunol Immunother. 2005 Apr;54(4):400-6. doi: 10.1007/s00262-004-0603-z. Epub 2004 Sep 24. Cancer Immunol Immunother. 2005. PMID: 15449039 Free PMC article.
-
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma.Genes Immun. 2022 Jun;23(3-4):129-140. doi: 10.1038/s41435-022-00172-w. Epub 2022 May 7. Genes Immun. 2022. PMID: 35525858 Free PMC article.
-
Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma.Front Immunol. 2021 Apr 22;12:650427. doi: 10.3389/fimmu.2021.650427. eCollection 2021. Front Immunol. 2021. PMID: 33968044 Free PMC article.
-
Cellular immunotherapy for neuroblastoma: a review of current vaccine and adoptive T cell therapeutics.Curr Pharm Des. 2009;15(4):424-9. doi: 10.2174/138161209787315765. Curr Pharm Des. 2009. PMID: 19199969 Free PMC article. Review.
-
HLA expression in human hepatocellular carcinoma.Br J Cancer. 1988 Apr;57(4):369-73. doi: 10.1038/bjc.1988.84. Br J Cancer. 1988. PMID: 2839219 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials